Design, synthesis and biological evaluation of 2,3-dihydroimidazo[2,1-b]thiazoles as dual EGFR and IGF1R inhibitors

Design, synthesis and biological evaluation of (E)-5-styryl-1,2,4-oxadiazoles as anti-tubercular agents

(2019) Abhay Atmaram Upare et al.   BIOORGANIC CHEMISTRY

Design, synthesis and biological evaluation of novel azaspiro analogs of linezolid as antibacterial and antitubercular agents

(2016) Pradip K. Gadekar et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer

(2015) O. T. Dale et al.   CARCINOGENESIS

P7170: A Novel Molecule with Unique Profile of mTORC1/C2 and Activin Receptor-like Kinase 1 Inhibition Leading to Antitumor and Antiangiogenic Activity

(2015) A. Jalota-Badhwar et al.   MOLECULAR CANCER THERAPEUTICS

RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy

(2013) Ruchi Tandon et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cellular Functions Regulated by Phosphorylation of EGFR on Tyr845

(2013) Ken-ichi Sato   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases

(2010) Steve D. Fidanze et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Combined inhibition of IGFR enhances the effects of gefitinib in H1650: a lung cancer cell line with EGFR mutation and primary resistance to EGFR-TK inhibitors

(2009) Yun Jung Choi et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Resistance to EGF-R (erbB-1) and VEGF-R modulating agents

(2009) Wolfram C.M. Dempke et al.   EUROPEAN JOURNAL OF CANCER

Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation

(2008) Julie L. Wilsbacher et al.   JOURNAL OF BIOLOGICAL CHEMISTRY